Suprita Krishna
Papers
5
Total Citations
200
H-Index
5
About
Dr. Suprita Krishna is a leading researcher in urologic oncology, with a focus on comparative effectiveness and surgical outcomes in bladder cancer treatment. Her work centers on evaluating the safety, efficacy, and peri-operative outcomes of robot-assisted radical cystectomy (RARC) versus open radical cystectomy (ORC). Dr. Krishna’s major contributions include leading large, international multicenter collaborations that provide robust, real-world evidence on surgical trends and outcomes. Her 2019 study, cited 82 times, revealed significant differences in the adoption of RARC across North America and Europe, while her 2018 comparative effectiveness paper (49 citations) demonstrated the nuanced benefits of robotic surgery. She also pioneered a standardized classification system for adverse events associated with the DaVinci Surgical System, using the FDA MAUDE database—a critical tool for improving device safety. With additional work on survival outcomes and surgical margins, Dr. Krishna’s research has directly informed clinical decision-making and patient counseling. Her ability to synthesize data from thousands of patients across continents underscores her impact on evidence-based urologic practice.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5